Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials) Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials)

Discovering Rare Variants by Use of Melting Temperature Shifts Seen in Melting Curve Analysis (Editorials‪)‬

Clinical Chemistry, 2005, August, 51, 8

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

Two reports in this issue of Clinical Chemistry describe novel mutations in thrombophilia genes (1, 2). The authors of the reports describe variants detected by the identification of a melting temperature ([T.sub.m]) different from the expected [T.sub.m] of the target mutation and from the [T.sub.m] of the wild-type sequence. The variants reported in this issue are A20218G in the prothrombin (factor II) gene and C1690T in the factor V gene. These cases add to the reported variants identified by fluorescent hybridization probes and melting analysis on the LightCycler. In addition to factor II and V variants, variants have been discovered similarly in genes coding for MTHFR and HFE (3, 4). Melting analyses, as performed on the LightCycler or similar instruments, can distinguish variants that lie within the region of the target probe. Differences in base composition, nucleotide position, and nearest-neighbor environments all affect [T.sub.m]. These differences are detected by monitoring fluorescence during an increase in temperature. Melting is visualized by a loss of fluorescence as the probes dissociate from the template. Differences in [T.sub.m] from the expected [T.sub.m] for wild-type and target mutations are indicative of a nontarget (a variant other than the mutation the assay was designed to detect) mutation or variant.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2005
1. August
SPRACHE
EN
Englisch
UMFANG
9
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
GRÖSSE
176,4
 kB

Mehr ähnliche Bücher

Selected Exonic Sequencing of the AGXT Gene Provides a Genetic Diagnosis in 50% of Patients with Primary Hyperoxaluria Type I (Molecular Diagnostics and Genetics) Selected Exonic Sequencing of the AGXT Gene Provides a Genetic Diagnosis in 50% of Patients with Primary Hyperoxaluria Type I (Molecular Diagnostics and Genetics)
2007
Does Phaster Mean Better?(Editorial) Does Phaster Mean Better?(Editorial)
1997
Methods for Detection of Point Mutations: Performance and Quality Assessment. Methods for Detection of Point Mutations: Performance and Quality Assessment.
1997
Chemical Diagnostics Chemical Diagnostics
2013
Gene Discovery for Disease Models Gene Discovery for Disease Models
2011
Comparative Genomics Comparative Genomics
2014

Mehr Bücher von Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998